BRAFi |
BRAF inhibitor |
AJCC |
American Joint Committee on Cancer |
MEKi |
Mitogen-activated protein inhibitor |
cSCCs |
Cutaneous squamous cell carcinomas |
UV |
Ultraviolet light |
MAPK |
Mitogen-activated protein kinase |
WT |
Wild-type |
HPV |
Human papillomavirus |
tg |
Transgenic |
MmuPV1 |
Mus musculus papillomavirus 1 |
CMC |
Carboxymethyl cellulose |
FFPE |
Formalin-fixed and paraffin-embedded |
M |
MmuPV1-infected mice |
B |
BRAF-inhibitor-treated mice |
U |
UVB-irradiated mice |
Ø |
Vehicle-treated mice |
MBU |
MmuPV1-infected, BRAFi-treated, UVB-irradiated mice |
MB |
MmuPV1-infected, BRAFi-treated mice |
MU |
MmuPV1-infected, UVB-irradiated mice |
BU |
BRAF-inhibitor-treated and UVB-irradiated mice |
DMSO |
Dimethyl sulfoxide |
K17 |
Keratin 17 |